Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS

Condition:   Multidrug Resistant Tuberculosis Interventions:   Drug: Bedaquiline;   Drug: Pyrazinamide;   Drug: Linezolid;   Drug: Cycloserine;   Drug: Clofazimine Sponsor:   Huashan Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials